Lamellarins as inhibitors of P-glycoprotein-mediated multidrug resistance in a human colon cancer cell line

Chemistry - An Asian Journal

Volumn 7, Issue 7, 2012, Pages 1616-1623

  Plisson, Fabien ^a   Huang, Xiao Cong ^a   Zhang, Hua ^a   Khalil, Zeinab ^a   Capon, Robert J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

cancer; inhibitor; lamellarin; multidrug resistance; p glycoprotein

Indexed keywords

CANCER; INHIBITOR; LAMELLARINS; MULTIDRUG RESISTANCE; P-GLYCOPROTEIN;

CELL CULTURE; CELLS; FISHERIES; SPECTROSCOPIC ANALYSIS; SYNTHETIC APERTURE RADAR;

GLYCOPROTEINS;

ALKALOID; ANTINEOPLASTIC AGENT; COUMARIN DERIVATIVE; FUSED HETEROCYCLIC RINGS; ISOQUINOLINE DERIVATIVE; MULTIDRUG RESISTANCE PROTEIN;

ANIMAL; ARTICLE; AUSTRALIA; CHEMISTRY; COLON TUMOR; DRUG ANTAGONISM; DRUG EFFECT; DRUG RESISTANCE; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MULTIDRUG RESISTANCE; STRUCTURE ACTIVITY RELATION; TUMOR CELL LINE; UROCHORDATA;

ALKALOIDS; ANIMALS; ANTINEOPLASTIC AGENTS; AUSTRALIA; CELL LINE, TUMOR; COLONIC NEOPLASMS; COUMARINS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HETEROCYCLIC COMPOUNDS WITH 4 OR MORE RINGS; HUMANS; ISOQUINOLINES; P-GLYCOPROTEIN; STRUCTURE-ACTIVITY RELATIONSHIP; UROCHORDATA;

EID: 84862571806     PISSN: 18614728     EISSN: 1861471X     Source Type: Journal    
DOI: 10.1002/asia.201101049     Document Type: Article

References (19)

1. H. Glavinas, P. Krajcsi, J. Cserepes, B. Sarkadi, Curr. Drug Delivery 2004, 1, 27-42.
2. C. Barthomeuf, M. L. Bourguet-Kondracki, J. M. Kornprobst, Anticancer Agents Med. Chem. 2008, 8, 886-903.
3. N. Aouali, L. Eddabra, J. Macadre, H. Morjani, Crit. Rev. Oncol. Hematol. 2005, 56, 61-70.
4. H. Fan, J. Peng, M. T. Hamann, J.-F. Hu, Chem. Rev. 2008, 108, 264-287.
5. J. Kluza, P. Marchetti, C. Bailly, in Modern Alkaloids: Structure, Isolation, Synthesis and Biology (Eds.:, E. Fattorusso, O. Taglialatela-Scafati, ), Wiley-VCH, Weinheim, 2008, pp. 171-187.
6. M. Vanhuyse, J. Kluza, C. Tardy, G. Otero, C. Cuevas, C. Bailly, A. Lansiaux, Cancer Lett. 2005, 221, 165-175.
7. A. R. Quesada, M. D. Garcia Gravalos, J. L. Fernandez Puentes, Br. J. Cancer 1996, 74, 677-682.
8. J. L. F. Puentes, D. Garcia Gravalos, A. R. Quesada, 1997, WO 9701336 (A1).
9. R. J. Andersen, D. J. Faulkner, C.-H. He, G. D. V. Duyne, J. Clardy, J. Am. Chem. Soc. 1985, 107, 5492-5495.
10. N. Lindquist, W. Fenical, G. D. V. Duyne, J. Clardy, J. Org. Chem. 1988, 53, 4570-4574.
11. A. R. Carroll, B. F. Bowden, J. C. Coll, Aust. J. Chem. 1993, 46, 489-501.
12. S. Urban, R. J. Capon, Aust. J. Chem. 1996, 49, 711-713.
13. M. V. R. Reddy, D. J. Faulkner, Y. Venkateswarlu, M. R. Rao, Tetrahedron 1997, 53, 3457-3466.
14. S. M. Reddy, M. Srinivasulu, N. Satyanarayana, A. K. Kondapi, Y. Venkateswarlu, Tetrahedron 2005, 61, 9242-9247.
15. P. Ploypradith, T. Petchmanee, P. Sahakitpichan, N. D. Litvinas, S. Ruchirawat, J. Org. Chem. 2006, 71, 9440-9448.
16. R. A. Davis, A. R. Carroll, G. K. Pierens, R. J. Quinn, J. Nat. Prod. 1999, 62, 419-424.
17. S. Scala, N. Akhmed, U. S. Rao, K. Paull, L. B. Lan, B. Dickstein, J. S. Lee, G. H. Elgemeie, W. D. Stein, S. E. Bates, Mol. Pharmacol. 1997, 51, 1024-1033.
18. C. J. Henrich, H. R. Bokesch, M. Dean, S. E. Bates, R. W. Robey, E. I. Goncharova, J. A. Wilson, J. B. McMahon, J. Biomol. Screening 2006, 11, 176-183.
19. C. J. Henrich, R. W. Robey, K. Takada, H. R. Bokesch, S. E. Bates, S. Shukla, S. V. Ambudkar, J. B. McMahon, K. R. Gustafson, ACS Chem. Biol. 2009, 4, 637-647.